WHO CDS CSR DRS[removed]ORIGINAL: ENGLISH DISTRIBUTION: GENERAL Resistant pneumococcal - Pneumococcal polysaccharide vaccine - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-06-02 18:26:42 Health Vaccines Bacterial diseases Pathogenic bacteria Microbiology Pneumococcal conjugate vaccine Pneumococcal vaccine Pneumococcal infection Pneumococcal polysaccharide vaccine Bacteria Medicine Pneumonia		WHO/CDS/CSR/DRS[removed]ORIGINAL: ENGLISH DISTRIBUTION: GENERAL Resistant pneumococcal Add to Reading List Source URL: apps.who.int Download Document from Source Website File Size: 300,00 KB Share Document on Facebook

	LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held DocID: 1rhtI - View Document
	HIN Logo_Color_Master_Standard Logo_CS2 DocID: 1qGRg - View Document
	ppsv - what you need to know- 508 compliant DocID: 1q1Yu - View Document
	Combioxin receives Clinical Trial Authorization to initiate a first-in-man study with CAL02 in patients with severe pneumococcal pneumonia GENEVA, SWITZERLAND, 12 January 2016 – Combioxin SA is pleased to announce that DocID: 1prxw - View Document
	BATTLING INFECTIONS OF THE CENTRAL NERVOUS SYSTEM Organisms, Risk Factors, and Laboratory Diagnostics Blake W. Buchan, PhD, D(ABMM) Email: Phone: DocID: 1oWg5 - View Document